Simon Authier, DVM, MSc, MBA, PhD, DSP presenting. 

- This session will discuss major considerations related to Electroencephalography (EEG) investigations: Study design, species selection, adverse event characterization, regulatory considerations, safety margins and translation from animals to humans will be discussed.

- Seizures may be observed with a wide range of therapeutic classes including antibiotics, gene therapy, oncology, analgesics, cognitive and movement disorder treatments

- EEG may be applied to all stages of drug development from discovery to late-stage GLP toxicology studies, based on specific considerations and program requirements.

- Seizure liability, sleep disturbance/drug induced insomnia, and stimulatory/sedative effects are only a few potential justifications for the addition of EEG in rodent or nonrodent neurotoxicology studies.

Intended audience Study Directors, Scientists, Veterinary staff members.